Uncategorized

Cell Based Delivery appoints new president

PBN Staff

12/23/2002

PROVIDENCE – Cell Based Delivery Inc., a biotechnology startup that attracted $9 million in venture capital earlier this year, recently named Thomas P. Mathers as its president and chief executive officer.

Mathers, 36, most recently was vice president and general manager of Cardion Pharmaceuticals Inc., the Boston-based subsidiary of a German biotech firm that is developing therapeutics for autoimmune disorders. Before that Mathers was the vice president of strategic development at biotech giant Genzyme Corp.

Dr. Hubert Birner, chairman of Cell Based Delivery’s board of directors, said Mathers provides strategic, operational and business-development experience “at a time of critical growth,” for the company. Cell Based Delivery is developing implantable protein-delivery systems to treat hematological and musculoskeletal disorders.

Astro-Med supplies technology
for Boeing satellite

WEST WARWICK – Astro-Med Inc. recently announced a partnership with a European broadband satellite company to develop a system for Boeing satellite systems.

The venture between Astro-Med and SES Global, based in Luxembourg, will design systems for automated phase check, attitude-data processing and attitude estimation for Boeing’s 376 satellite systems. During station-keeping maneuvers, the satellite’s attitude control system is used to fire a thruster that moves the satellite back to where it belongs if it drifts out of position.

Astro-Med said there is potentially large market demand for Boeing’s 376 satellite system from satellite operators in the United States and in international markets. Astro-Med’s technology is called the Everest Telemetry Recorder Workstation, which is developed by Astro-Med’s Test and Measurement Systems Product Group.

PBN Branded Content